Twist Bioscience Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0ME.MU | 1548.HK | WVE | XLS.SW | SONM | 88Q.F | |
|---|---|---|---|---|---|---|
| Market cap | — | 76.81B | 713.97M | 50.40M | 3.83M | 92.91M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | 85.8 | -3.1 | -3.0 | 3.1 | — |
| Price/book | 22.6 | 2.4 | 1.8 | 0.4 | -3.1 | 61.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −23.15% | +109.10% | −54.06% | −52.11% | −77.67% | −28.57% |
| Today | +6.37% | −0.94% | +1.12% | 0.00% | +1.98% | 0.00% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All 0ME.MU news ›Twist Bioscience Soars 12%, 10x Genomics Up 12% as Genomics Stocks Rebound
max-kegfire from Getty Images via Canva Twist Bioscience (TWST) stock jumped 12% today, and 10x Genomics (TXG) rose 12% right alongside it. Neither company had news to explain the move. Twist’s only release was the launch of a new…
Twist Bioscience Launches Custom MRD Panels for Cancer Assay Development
Twist Bioscience launches Twist MRD Express, offering custom molecular residual disease panels with turnaround times starting within one day. The new platform offers custom panel manufacturing in as little as one day to support development…
Twist Bioscience (TWST) Gets a Buy from Leerink Partners
Leerink Partners analyst Puneet Souda maintained a Buy rating on Twist Bioscience today and set a price target of $190.00. Souda covers the Healthcare sector, focusing on stocks such as Twist Bioscience, 10x Genomics, and Bruker. According…
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.…
Research Analysts’ Weekly Ratings Changes for Twist Bioscience (TWST)
Twist Bioscience (NASDAQ: TWST) recently received a number of ratings updates from brokerages and research firms: 10/13/2026 – Twist Bioscience had its price target raised by TD Cowen from $115.00 to $190.00. They now have a “buy” rating…
Twist Bioscience Sinks 9%, Illumina Down 5% as AI and Genomics Stocks Slide
@Delia Pindaru's Images via Canva Twist Bioscience (TWST) shares are down 9% today, and the company didn’t even do anything to deserve it this time. It has company. Illumina (ILMN) is down 5% as the tech-heavy Nasdaq slid more than 2%…
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
Learn how to accelerate your research with Twist Genes Read our app note on Twist Oligo Pools for CRIPSR screens Twist's Whole Exome Library Preparation Workflow. Learn More > Watch how Twist builds variant libraries for your perfect…
Comparing iSpecimen (NASDAQ:ISPC) and Twist Bioscience (NASDAQ:TWST)
Posted by Defense World Staff on Oct 19th, 2026 Twist Bioscience (NASDAQ:TWST – Get Free Report) and iSpecimen (NASDAQ:ISPC – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two…
Twist Bioscience CEO sells 45,736 shares for taxes
Another 655 shares sold at $200 on October 1 under a trading plan adopted June 15; the October 2 tax-covering sale priced shares at $188.884. - [Form 4] Twist Bioscience Corp Insider Trading Activity Twist Bioscience CEO sells 45,736…
Twist Bioscience CFO sells 8,057 shares for taxes
Sold at $188.8840 per share on October 2, 2026, Adam Laponis's shares covered tax withholding tied to stock vesting; the sale was not discretionary. - [Form 4] Twist Bioscience Corp Insider Trading Activity Twist Bioscience CFO sells 8,057…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net6
- defenseworld.net4
- stockstotrade.com4
- timothysykes.com3
- tikr.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 26 articles, not a forecast.